Medical Therapy of Heart Failure with Reduced Ejection Fraction—A Call for Comparative Research - Sorbonne Université Accéder directement au contenu
Article Dans Une Revue Journal of Clinical Medicine Année : 2021

Medical Therapy of Heart Failure with Reduced Ejection Fraction—A Call for Comparative Research

Gad Cotter
  • Fonction : Auteur
  • PersonId : 1097595
Koji Takagi
  • Fonction : Auteur
  • PersonId : 1097597
Maria Novosadova
  • Fonction : Auteur
  • PersonId : 1097598
Alain Cohen-Solal
  • Fonction : Auteur
  • PersonId : 1079488

Résumé

The armamentarium of therapies for patients with heart failure and reduced ejection fraction (HFREF) has increase substantially with the introduction of Angiotensin Receptor Neprilysin Inhibitor (ARNi), sodium glucose cotransport inhibitors (SGLTis), ivabradine, and Vericinguat, bringing to seven the number of potential therapies for HFREF. In the current review we highlight available data on the different classes of medications. Renin angiotensin blockers (RAASbs) and beta blockers (BBs) were shown to have very substantial effects in patients with HFREF. These medications are generic and hence relatively inexpensive. They have a 30-year track record of relatively benign short- and long-term safety profiles and should remain the cornerstone of therapy for patients with HFREF. ARNis are effective in further reducing adverse effects and should replace RAASbs in symptomatic HFREF patients, despite their relatively high prices. The addition of SGLTis (congested patients), Ivabradine (tachycardic patients), and Vericinguat (hypertensive patients) should be considered in patients who remain symptomatic despite optimal doses of RAASbs/ARNis, MRAs, and BBs. Comparative studies examining the efficacy of these medications, and strategies and prioritizing some over others should be considered as, given their similar side effects on heart rate, blood pressure, and renal function, it is highly unlikely that all can be given to the same patient.
Fichier principal
Vignette du fichier
jcm-10-01803.pdf (204.98 Ko) Télécharger le fichier
Origine : Publication financée par une institution

Dates et versions

hal-03215425 , version 1 (03-05-2021)

Identifiants

Citer

Gad Cotter, Beth A Davison, Alexandre Mebazaa, Koji Takagi, Maria Novosadova, et al.. Medical Therapy of Heart Failure with Reduced Ejection Fraction—A Call for Comparative Research. Journal of Clinical Medicine, 2021, 10 (9), pp.1803. ⟨10.3390/jcm10091803⟩. ⟨hal-03215425⟩
47 Consultations
52 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More